1. Home
  2. BDSX vs AGD Comparison

BDSX vs AGD Comparison

Compare BDSX & AGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$6.71

Market Cap

62.5M

Sector

Health Care

ML Signal

HOLD

Logo abrdn Global Dynamic Dividend Fund of Beneficial Interest

AGD

abrdn Global Dynamic Dividend Fund of Beneficial Interest

HOLD

Current Price

$11.60

Market Cap

288.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDSX
AGD
Founded
2005
2006
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Precision Instruments
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
62.5M
288.1M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
BDSX
AGD
Price
$6.71
$11.60
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$32.50
N/A
AVG Volume (30 Days)
69.7K
61.2K
Earning Date
11-03-2025
01-01-0001
Dividend Yield
N/A
8.13%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$80,173,000.00
N/A
Revenue This Year
$20.75
N/A
Revenue Next Year
$25.05
N/A
P/E Ratio
N/A
N/A
Revenue Growth
22.29
N/A
52 Week Low
$3.44
$8.20
52 Week High
$31.20
$9.78

Technical Indicators

Market Signals
Indicator
BDSX
AGD
Relative Strength Index (RSI) 42.52 47.12
Support Level $6.55 $11.71
Resistance Level $7.03 $12.30
Average True Range (ATR) 0.52 0.20
MACD -0.10 0.03
Stochastic Oscillator 25.79 27.84

Price Performance

Historical Comparison
BDSX
AGD

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About AGD abrdn Global Dynamic Dividend Fund of Beneficial Interest

Aberdeen Global Dynamic Dividend Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current dividend income, more than 50% of which qualifies for the reduced federal income tax rate, as created by the Jobs and Growth Tax Relief Reconciliation Act of 2003. The fund also focuses on the long-term growth of capital as a secondary investment objective. The fund's portfolio holdings are in information technology, financials, health care, and consumer discretionary sectors among others.

Share on Social Networks: